Table I.
Characteristics | Number of patients (%) | Relative expression | P-value |
---|---|---|---|
Age (years) | |||
<45 | 26 (45.6) | 0.75±0.16 | 0.1933 |
≥45 | 31 (54.4) | 0.52±0.09 | |
Sex | |||
Male | 17 (29.8) | 0.76±0.20 | 0.1571 |
Female | 40 (70.2) | 0.45±0.11 | |
Tumor size (cm) | |||
<2 | 49 (86.0) | 0.70±0.14 | 0.1246 |
≥2 | 8 (14.0) | 0.17±0.08 | |
TNM stage | |||
I–II | 42 (73.7) | 0.77±0.20 | 0.1515 |
III–IV | 15 (26.3) | 0.28±0.11 | |
Multifocality | |||
Yes | 30 (52.6) | 0.61±0.09 | 0.4660 |
No | 27 (47.4) | 0.48±0.16 | |
Extrathyroidal extension | |||
Yes | 12 (21.1) | 0.69±0.26 | 0.8503 |
No | 45 (78.9) | 0.63±0.18 | |
LNM | |||
Yes | 32 (56.1) | 0.82±0.13 | <0.001a |
No | 25 (43.9) | 0.25±0.05 |
P<0.001. circ, circular RNA; TNM, tumor-node-metastasis; LNM, lymph node metastasis.